KR100196462B1 - Novel pyrrolidine derivatives and process for the preparations thereof - Google Patents
Novel pyrrolidine derivatives and process for the preparations thereof Download PDFInfo
- Publication number
- KR100196462B1 KR100196462B1 KR1019940029176A KR19940029176A KR100196462B1 KR 100196462 B1 KR100196462 B1 KR 100196462B1 KR 1019940029176 A KR1019940029176 A KR 1019940029176A KR 19940029176 A KR19940029176 A KR 19940029176A KR 100196462 B1 KR100196462 B1 KR 100196462B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- general formula
- pyrrolidine
- same
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
- C07D203/12—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
본 발명은 다음 일반식(Ⅰ)로 표시되는 새로운 피롤리딘 유도체 및 이를 제조하는 방법에 관한 것이다.The present invention relates to a novel pyrrolidine derivative represented by the following general formula (I) and a method for producing the same.
상기식 중에서 M은 할로겐, -OR1또는 -SR2이고(여기서 R1, R2는 서로 같거나 다르며, 각각 수소원자 또는 탄소수 1-3개의 저급알킬기를 나타낸다.), n은 1 또는 2의 정수이다.Wherein M is halogen, -OR 1 or -SR 2 (wherein R 1 , R 2 are the same as or different from each other, each represent a hydrogen atom or a lower alkyl group of 1 to 3 carbon atoms), and n is 1 or 2 Is an integer.
일반식(Ⅰ)로 표시된 화합물은 3번 위치의 비대칭탄소로 인한 광학이성질체를 포함한다. 또한 본 발명은 상기 일반식(Ⅰ)화합물의 제조방법을 제공하는 것이다.Compounds represented by formula (I) include optical isomers due to the asymmetric carbon at position 3. The present invention also provides a method for preparing the general formula (I) compound.
Description
본 발명은 다음 일반식(Ⅰ)로 표시되는 새로운 피롤리딘 유도체와 그 제조방법에 관한 것이다.The present invention relates to a novel pyrrolidine derivative represented by the following general formula (I) and a preparation method thereof.
상기식 중에서 M는 할로겐 원자, -OR1또는 -SR2이고(여기서 R1, R2는 서로 같거나 다르며, 각각 수소원자 또는 탄소수 1-3개의 저급 알킬기를 나타낸다.), n은 1 또는 2의 정수이다.Wherein M is a halogen atom, -OR 1 or -SR 2 (wherein R 1 , R 2 are the same as or different from each other, each represent a hydrogen atom or a lower alkyl group having 1 to 3 carbon atoms), and n is 1 or 2 Is an integer.
일반식(Ⅰ)로 표시된 화합물은 3번 위치의 비대칭 탄소로 인한 광학적 이성질체를 포함한다. 따라서 모든 광학 이성질체 및 그들의 혼합물은 편리상 단일 구조식으로 표기한다. 따라서 본 발명의 범위는 광학 이성질체 또는 그들의 혼합물 중 하나에 재한되는 것은 아니다.Compounds represented by formula (I) include optical isomers due to the asymmetric carbon at position 3. Therefore, all optical isomers and mixtures thereof are conveniently expressed as single structural formula. Thus, the scope of the invention is not limited to either optical isomers or mixtures thereof.
일반적으로 퀴놀론 카르복실산 항균제는 뛰어난 항균력과 광범위한 항균 활성화합물로서 이미 널리 사용되고 있으며 그 대표적인 예로서 노플록사신, 에녹사신, 시프로플록사신 및 오플록사신 등이 현재 시판중에 있다.In general, the quinolone carboxylic acid antimicrobial agent is already widely used as an excellent antimicrobial activity and a wide range of antimicrobial active compounds, and representative examples thereof are nofloxacin, enoxacin, ciprofloxacin, and oploxacin.
그러나 이들 항균제의 경우 그람 음성균에 대해서는 탁월한 항균력을 보여주지만 그람 양성균에 대해서는 그 항균력이 현저히 떨어지고 또한 내성균 발현으로 인하여 새로운 항균제 개발이 요구되어져 왔다.However, these antimicrobial agents show excellent antimicrobial activity against gram-negative bacteria, but the antimicrobial activity of Gram-positive bacteria is significantly lowered and development of new antimicrobial agents has been required due to the expression of resistant bacteria.
이에 본 발명자들은 상술한 바와 같은 퀴놀론계 항균제의 단점을 보완하기 위해 기존의 퀴놀론 모핵의 C-7 위치에 새로운 도입기를 찾아내려는 연구 결과 본 발명을 완성하게 되었다.Accordingly, the present inventors have completed the present invention as a result of finding a new introducer at the C-7 position of the existing quinolone mother nucleus in order to compensate for the disadvantage of the quinolone antibacterial agent as described above.
따라서 본 발명은 퀴놀론계 항균화합물에 도입되는 매우 유용한 중간체를 제공하는 데 그 목적이 있다.It is therefore an object of the present invention to provide very useful intermediates to be incorporated into quinolone antibacterial compounds.
이러한 본 발명의 신규한 상기 일반식(Ⅰ)의 화합물 제조방법을 살펴보면 다음의 반응식과 같이 공지 화합물인 다음 일반식(Ⅱ)로 표시되는 화합물을 출발물질로 한다.Looking at the novel method for preparing a compound of the general formula (I) of the present invention as a starting material is a compound represented by the following general formula (II) known compounds as shown in the following scheme.
일반식(Ⅱ)로 표시되는 화합물에다 트리에틸아민과 같은 염기존재 하에 에틸 2,3-디브로모프로피오네이트와 고리화 반응을 실시하여 일반식(Ⅲ)인 아지리딘 고리를 만든 다음 리튬 알루미늄 하이드라이드를 사용하여 다음 일반식(Ⅳ)로 표시되는 알콜 화합물을 제조한 후 10% 팔라듐을 촉매로 사용한 수소 반응을 통해 벤질기를 제거하여 M이 히드록시기인 상기 일반식(Ⅰ)의 목적화합물을 합성한다.The compound represented by formula (II) was subjected to a cyclization reaction with ethyl 2,3-dibromopropionate in the presence of a base such as triethylamine to form aziridine ring of formula (III), followed by lithium aluminum The hydride was used to prepare an alcohol compound represented by the following general formula (IV), and then benzyl group was removed by hydrogen reaction using 10% palladium as a catalyst to synthesize the target compound of the general formula (I), wherein M is a hydroxy group. do.
그 합성경로를 나타내면 다음의 공정도와 같다The synthetic route is shown in the following process chart.
상기식 중에서 M 및 n은 앞에서 정의한 바와 같다.In the formula, M and n are as defined above.
상기 일반식(Ⅰ)에서의 다양한 작용기의 도입은 일반식(Ⅳ)를 출발물로 합성한다.The introduction of various functional groups in the general formula (I) synthesizes the general formula (IV) as a starting material.
일반식(Ⅳ)에서 염화티오닐을 사용하여 일반식(Ⅴ)의 염소기를 도입하며, 일반식(Ⅵ)의 메탄술포닐 유도체로 전환시킨 다음 테트라 암모늄플루오라이드를 사용한 치환반응올 통해 불소기를 도입하여 일반식(Ⅶ)을 제조한다.In the general formula (IV), thionyl chloride is used to introduce a chlorine group of the general formula (V), and is converted to a methanesulfonyl derivative of the general formula (VI), and then a fluorine group is introduced through a substitution reaction using tetraammonium fluoride. To produce a general formula (Ⅶ).
일반식(Ⅴ)와 (Ⅶ)의 수소반응을 통하여 일반식(Ⅰ)에서 M이 각각 염소와 불소인 목적화합물을 얻는다.Hydrogen reactions of formulas (V) and (iii) yield the desired compounds in which M is chlorine and fluorine, respectively.
이와같이, 본 발명에 따라 제조된 상기 일반식(Ⅰ)의 새로운 피롤리딘 유도체는 항균활성을 갖는 각종 퀴놀론 유도체 화합물 제조시 도입기로 이용되는 원료화합물인 중간체로서 매우 유용하며 이러한 본 발명의 신규 화합물을 모핵에 도입한 퀴놀론 항균제는 뛰어난 항균활성을 나타낸다.As such, the novel pyrrolidine derivatives of the general formula (I) prepared according to the present invention are very useful as intermediates, which are raw materials used as introduction materials in the preparation of various quinolone derivative compounds having antimicrobial activity, and the novel compounds of the present invention Quinolone antimicrobial agent introduced into the mother nucleus shows excellent antimicrobial activity.
이하, 본 발명을 실시예로서 상세히 설명하는 바, 본 발명이 다음의 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by way of examples, but the present invention is not limited by the following examples.
[실시예 1]Example 1
1-벤질-3-(2-에톡시카르보닐)아지리디노 피롤리딘의 제조(Ⅲ)Preparation of 1-benzyl-3- (2-ethoxycarbonyl) aziridino pyrrolidine (III)
1-벤질-3-아미노 피롤리딘 10.5g(59.7mmol)을 200ml의 아세토니트릴에 넣고 트리에틸아민 16.64g(119.4mmol)과 에틸 2,3-디브로모프로피오네이트 8.67ml(59.7mmol)을 차례로 가하여 상온에서 3시간동안 교반하였다.10.5 g (59.7 mmol) of 1-benzyl-3-amino pyrrolidine was added to 200 ml of acetonitrile and 16.64 g (119.4 mmol) of triethylamine and 8.67 ml (59.7 mmol) of ethyl 2,3-dibromopropionate It was added sequentially and stirred for 3 hours at room temperature.
반응 중에 생선된 염을 여과하여 여과액을 모아 농축시킨 다음 다클로로메탄 200ml에 희석시키고 포화탄산수소나트륨 용액으로 세척한 다음(100ml×2)건조시켜 목적화합물 13.95g을 얻었다. (수득율 86%)The fish salted during the reaction was filtered, and the filtrate was collected, concentrated, diluted with 200 ml of dichloromethane, washed with saturated sodium hydrogen carbonate solution (100 ml × 2), and dried to obtain 13.95 g of the target compound. (86% yield)
[실시예 2]Example 2
1-벤젤-3-(2-히드록시메틸)아지리디노 피롤리딘의 제조(Ⅳ)Preparation of 1-benzel-3- (2-hydroxymethyl) aziridino pyrrolidine (IV)
무수 테트라히드로퓨란 용매 200ml에 묽힌 1-벤질-3(2-에톡시카르보닐)아지리디노피롤리딘 13.95g(51.1mmol)에 질소 분위기를 유지하며 -10℃에서 리튬 알루미늄 하이드리이드 1.94g(51.1mmol)을 가한 후 상온에서 5시간 교반시켰다.13.95 g (51.1 mmol) of 1-benzyl-3 (2-ethoxycarbonyl) aziridinopyrrolidine diluted in 200 ml of anhydrous tetrahydrofuran solvent is maintained in nitrogen atmosphere and 1.94 g of lithium aluminum hydride (51.1) at -10 ° C. mmol) was added and stirred at room temperature for 5 hours.
증류수 2ml와 15%수산화나트륨 용액 2ml을 차례로 가한 후 여과하여 여액을 농축시킨 뒤 에틸 아세테이트 200ml에 묽혀 물로 세척하고 건조 후 농축시켜 목적화합물 8.1g을 얻었다.(수득률 67.5%)2 ml of distilled water and 2 ml of 15% sodium hydroxide solution were added sequentially, and then the filtrate was concentrated by filtration, diluted with 200 ml of ethyl acetate, washed with water, dried and concentrated to obtain 8.1 g of the target compound (yield 67.5%).
[실시예 3]Example 3
3-(2-히드록시메틸)아지리디노 피롤리딘의 제조(Ⅰ)Preparation of 3- (2-hydroxymethyl) aziridino pyrrolidine (I)
1-벤질-3-(2-히드록시메틸)아지리디노 피롤리딘 1.2g(5.7mmol)을 에탄올 150ml에 묽힌 후 10% 팔라듐 0.6g을 넣고 60℃에서 4-5바아(bar)의 수소 압력으로 5시간 동안 교반시켰다.Dilute 1.2 g (5.7 mmol) of 1-benzyl-3- (2-hydroxymethyl) aziridino pyrrolidine in 150 ml of ethanol, add 0.6 g of 10% palladium, and hydrogen pressure of 4-5 bar at 60 ° C. Stirred for 5 hours.
반응물을 여과하여 감압하에 농축시켜 620mg을 얻었다. (수득률 85%)The reaction was filtered and concentrated under reduced pressure to give 620 mg. (85% yield)
[실시예 4]Example 4
1-벤질-3-(2-메탄설포닐히드록시메틸)아지리디노 피롤리딘의 제조(Ⅳ)Preparation of 1-benzyl-3- (2-methanesulfonylhydroxymethyl) aziridino pyrrolidine (IV)
1-벤질-3-(2-히드록시메틸)아지리디노 피롤리딘 2.4g(10mmol)을 디클로로메탄50ml에 묽히고 트리에틸아민 2.78ml(20mmol)을 가한 후 0℃에서 메탄술포닐 클로라이드 1.21ml(15mmol)을 천천히 적가한다.2.4 g (10 mmol) of 1-benzyl-3- (2-hydroxymethyl) aziridino pyrrolidine was diluted in 50 ml of dichloromethane, 2.78 ml (20 mmol) of triethylamine was added, and 1.21 ml of methanesulfonyl chloride at 0 ° C. (15 mmol) is slowly added dropwise.
3시간 동안 상온에서 교반시키고 반응용기에 얼음물 10ml를 첨가한 다음 디클로로메탄과 포화탄산수소나트륨 용액으로 추출한 후 건조하여 농축시켜 3.2g의 목적화합물을 얻었다. (수득률 92%)After stirring for 3 hours at room temperature, 10 ml of ice water was added to the reaction vessel, extracted with dichloromethane and saturated sodium hydrogen carbonate solution, dried and concentrated to obtain 3.2 g of the target compound. (92% yield)
[실시예 5]Example 5
1-벤질-2-(2-플로오르메틸)아지리디노 피롤리딘의 제조(Ⅶ)Preparation of 1-benzyl-2- (2-fluoromethyl) aziridino pyrrolidine
1-벤질-3-(2-메탄술포닐히드록시메틸)아지리디노 피롤리딘 1.11g(3.6mmol)을 무수테트라히드로 퓨란 30ml에 묽히고 테트라부틸 암모늄플루오라이드 10.6ml(10.8mmol)을 가하여 1시간 동안 환류시킨다.1.11 g (3.6 mmol) of 1-benzyl-3- (2-methanesulfonylhydroxymethyl) aziridino pyrrolidine was diluted with 30 ml of anhydrous tetrahydrofuran and 10.6 ml (10.8 mmol) of tetrabutyl ammonium fluoride were added to give 1 Reflux for time.
용매를 농축시킨 다음 50ml의 에틸아세테이트에 묽히고 포화탄산수소나트륨으로 씻어준 다음 건조 후 농축시켜 실리카겔 칼럼크로마토그래피로 분리 정제하여 목적화합물 0.53g을 얻었다.(수득률 64%)The solvent was concentrated, diluted with 50 ml of ethyl acetate, washed with saturated sodium hydrogen carbonate, dried, concentrated and separated and purified by silica gel column chromatography to obtain 0.53 g of the target compound. (Yield 64%)
[실시예 6]Example 6
3-(2-플루오르메틸)아지리디노 피롤리딘의 제조(Ⅰ)Preparation of 3- (2-fluoromethyl) aziridino pyrrolidine (I)
1-벤질-3-(2-플로오르메틸)아지리디노 피롤리딘 0.53g(2.3mmol)을 출발물로 실시예 2의 방법과 동일한 조건으로 반응하여 목적화합물 0.21g을 얻었다.(수득률 72%)0.51 g (2.3 mmol) of 1-benzyl-3- (2-fluoromethyl) aziridino pyrrolidine was reacted as a starting material under the same conditions as in Example 2 to obtain 0.21 g of the target compound. (Yield 72% )
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019940029176A KR100196462B1 (en) | 1994-11-08 | 1994-11-08 | Novel pyrrolidine derivatives and process for the preparations thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019940029176A KR100196462B1 (en) | 1994-11-08 | 1994-11-08 | Novel pyrrolidine derivatives and process for the preparations thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR960017659A KR960017659A (en) | 1996-06-17 |
KR100196462B1 true KR100196462B1 (en) | 1999-06-15 |
Family
ID=19397348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019940029176A KR100196462B1 (en) | 1994-11-08 | 1994-11-08 | Novel pyrrolidine derivatives and process for the preparations thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100196462B1 (en) |
-
1994
- 1994-11-08 KR KR1019940029176A patent/KR100196462B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR960017659A (en) | 1996-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4174316A (en) | 4-Iodomethylazetidin-2-one | |
KR960015002B1 (en) | Optically active 8-methoxyquinolonecarboxylic acid derivatives | |
HU205116B (en) | Process for producing 1,4-diazabicyclo/3.2.2./nonane | |
GB1598668A (en) | Indolyloxymethyl-2-oxazolidinone derivatives and their use in the preparation of 1-amino-3-(indolyloxy)-2-propanols | |
KR100196462B1 (en) | Novel pyrrolidine derivatives and process for the preparations thereof | |
SU869558A3 (en) | Method of producing azetidinone derivatives | |
JP3989832B2 (en) | Process for the preparation of N-protected-3-pyrrolidine-lactam substituted phosphonium salts | |
GB1571835A (en) | Aminocyclols | |
US5202443A (en) | Process for preparing 1-(2s)-3-mercapto-methyl-1-oxopropyl)-l-proline | |
KR100209298B1 (en) | Novel amino-cyclic compound | |
KR100241263B1 (en) | Process for preparing n-alkyloxycarbonyl-beta-alkylsufonvaline | |
KR100209299B1 (en) | Novel aminocyclic compounds | |
KR100377289B1 (en) | Novel method of optical resolution for synthesis of intermediate of novel pyridinecarboxylic acid derivative | |
EP0916657B9 (en) | 1-phenylpyrrolidone derivatives having optical activity | |
KR810000859B1 (en) | Method for preparing derivatives of 7-amino- 3-desacetoxy cephalosporanic acid | |
KR900007314B1 (en) | Process for preparing n-(methoxyacetyl)-n-(2,l-dimethyl phenyl)-o-amino-oxazolidine-2-one | |
JP2905931B2 (en) | Process for producing optically active 2-cyclopentenones | |
KR940008423B1 (en) | 3,6-diazabicyclo£3,1,0| hexan compounds | |
KR100684081B1 (en) | Preparation of optically active 3,4-dihydrobenzoxazine derivative | |
KR910002154B1 (en) | 3-pyrroline derivatives and their preparation | |
KR100334462B1 (en) | A process for producing ethyl 2-(2,3,4,5-tetrafluorobenzoyl)-3(S)-(1-hydroxyprop-2-ylamino)acrylate | |
KR100390549B1 (en) | Method for manufacturing 3-halomethyl-3-cephem | |
KR930008224B1 (en) | Process for the production of pyrrolidine derivatives | |
US4758666A (en) | Process for the preparation of an apovincaminol derivative | |
KR100199101B1 (en) | New amine compounds and their acid salts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20031203 Year of fee payment: 6 |
|
LAPS | Lapse due to unpaid annual fee |